Cutting Edge TMS Treatment

Our Technology

Cutting-Edge TMS Powered by FirstPath AI
At Genesis TMS, we use FDA-approved, non-invasive Transcranial Magnetic Stimulation (TMS), enhanced by the breakthrough intelligence of FirstPath AI. This means your treatment isn’t just cutting-edge—it’s designed around you.

FirstPath AI helps us deliver more precise and effective care for depression, OCD, and other approved conditions, giving patients new hope when other treatments haven’t worked. Even better, this advanced therapy is now covered by most major insurance plans, so life-changing care is within reach.

The Science of Modern TMS

Transcranial Magnetic Stimulation (TMS) has undergone remarkable refinement since its initial FDA approval for the treatment of Major Depressive Disorder (MDD) in 2008. Modern TMS platforms employ high-frequency, precision-guided magnetic pulses to modulate cortical excitability and restore functional connectivity across key brain networks implicated in psychiatric illness.

Neuroimaging and electrophysiological studies demonstrate that TMS can normalize dysregulated activity in circuits governing mood regulation, executive control, and emotional processing. By inducing long-term potentiation and depression at the synaptic level, TMS facilitates durable neuroplastic changes that underlie clinical improvement.

This convergence of neuroscience, technology, and clinical research positions TMS as one of the most advanced, evidence-based neuromodulation therapies available in modern psychiatry.

Modern TMS
TMS Treatment
How TMS Works
Enhancing Neuroplasticity TMS promotes adaptive brain plasticity by stimulating the formation of new synaptic pathways and strengthening existing ones. This process supports long-term changes in how neural circuits process mood and cognition.
Restoring Network Connectivity Through precision-guided stimulation, TMS helps normalize functional connectivity between key brain regions involved in mood regulation, executive control, and emotional processing, restoring balanced communication across disrupted networks.
Modulating Neurotransmitter Systems Research shows that TMS influences critical neurochemical systems, including serotonin, dopamine, and glutamate, helping to rebalance the neurotransmitters essential for stable mood and mental health.
Unlike traditional medications that act systemically and often cause unwanted side effects, TMS provides targeted, localized neuromodulation. Each treatment protocol is tailored to an individual’s unique brain physiology, offering a safe and highly personalized approach to care.

The Treatment Experience

At Genesis TMS, we integrate advanced technology and patient-centered design to create a treatment experience that is both effective and seamless:

Pre-Treatment Brain Mapping Each patient undergoes precise brain mapping, incorporating advanced imaging and neuro-navigation to identify individualized stimulation targets.

Personalized Protocol Development Treatment parameters are tailored to your unique neurophysiology, ensuring optimal outcomes while minimizing unnecessary stimulation.

Comfort-Focused Design Our systems are engineered for patient comfort, with adaptive protocols and continuous evaluation to ensure a positive treatment experience.

Real-Time Response Monitoring We track neural and clinical response patterns in real time, allowing ongoing refinement of treatment to maximize effectiveness.

Mobile Companion App Patients gain access to an integrated app that supports progress tracking, appointment management, and evidence-based mental health resources.

Our Advanced TMS Systems

Genesis TMS leverages next-generation neuromodulation platforms, representing the forefront of TMS technology in 2025. These systems integrate AI-driven precision targeting, adaptive stimulation algorithms, and real-time data analytics to deliver unparalleled accuracy, personalization, and clinical outcomes.

Accelerated Protocols

We offer Stanford-developed accelerated TMS protocols that can significantly reduce treatment duration while maintaining or improving efficacy:

  • Standard protocol:
    36 sessions over 6-8 weeks.
  • Accelerated protocol: 10 sessions over 5 days, followed by maintenance sessions.

Expanded Treatment Applications

While initially FDA-approved for depression, TMS technology has expanded to treat multiple conditions:
  • Major Depressive Disorder (MDD) – Our primary FDA-approved application.
  • Treatment-Resistant Depression –For patients who haven’t responded to medications.
  • OCD –
    FDA-approved for obsessive-compulsive disorder.
  • Smoking Cessation – Helping reduce cravings and dependency.
  • Post-Traumatic Stress Disorder – Alleviating symptoms through targeted stimulation.
  • ADHD

Brain Wellness Starts Here

Schedule Your Next Appointment Today!